InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-11.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Engelbert Catherine M., Directeur. Director active across 2 companies, notably Royalty Pharma plc. Aggregated, 9 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €228k. Activity tracked since 25 June 2021. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
4,545 shares0Class A Ordinary SharesSEC:0001796439-26-000003:0
7,614 shares0Class A Ordinary SharesSEC:0001802768-25-000061:0
9,293 shares0Class A Ordinary SharesSEC:0001802768-24-000029:0
38 shares@ US$281.034.3% of flowCommon StockSEC:0000063908-23-000078:0
Ideal exit: 29 Dec 2023 (T+270)
7,747 shares0Class A Ordinary SharesSEC:0001209191-23-039681:0
6,328 shares0Class A Ordinary SharesSEC:0000899243-22-024044:0
1,000 shares@ US$244.180.0001% mcap100.0% of flowCommon StockSEC:0001567619-22-006022:0
Ideal exit: 25 Nov 2022 (T+270)
5,726 shares0Class A Ordinary SharesSEC:0000950103-21-009687
5,726 shares0Class A Ordinary SharesSEC:0000950103-21-009687:0
9 of 9 declarations
About Engelbert Catherine M.
Catherine M. Engelbert is a Director at Royalty Pharma plc and MCDONALDS CORP. She contributes to the strategic direction of these companies, bringing her experience to strengthen their market position.
